These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 21140207)

  • 1. A variant affecting miRNAs binding in the circadian gene Neuronal PAS domain protein 2 (NPAS2) is not associated with breast cancer risk.
    Wang F; Hu Z; Yang R; Tang J; Liu Y; Hemminki K; Sutter C; Wappenschmidt B; Niederacher D; Arnold N; Meindl A; Bartram CR; Schmutzler RK; Burwinkel B; Shen H
    Breast Cancer Res Treat; 2011 Jun; 127(3):769-75. PubMed ID: 21140207
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Non-synonymous polymorphisms in the circadian gene NPAS2 and breast cancer risk.
    Zhu Y; Stevens RG; Leaderer D; Hoffman A; Holford T; Zhang Y; Brown HN; Zheng T
    Breast Cancer Res Treat; 2008 Feb; 107(3):421-5. PubMed ID: 17453337
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation between circadian gene variants and serum levels of sex steroids and insulin-like growth factor-I.
    Chu LW; Zhu Y; Yu K; Zheng T; Chokkalingam AP; Stanczyk FZ; Gao YT; Hsing AW
    Cancer Epidemiol Biomarkers Prev; 2008 Nov; 17(11):3268-73. PubMed ID: 18990770
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polymorphisms in circadian genes, night work and breast cancer: results from the GENICA study.
    Rabstein S; Harth V; Justenhoven C; Pesch B; Plöttner S; Heinze E; Lotz A; Baisch C; Schiffermann M; Brauch H; Hamann U; Ko Y; Brüning T;
    Chronobiol Int; 2014 Dec; 31(10):1115-22. PubMed ID: 25229211
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A genetic variant in the pre-miR-27a oncogene is associated with a reduced familial breast cancer risk.
    Yang R; Schlehe B; Hemminki K; Sutter C; Bugert P; Wappenschmidt B; Volkmann J; Varon R; Weber BH; Niederacher D; Arnold N; Meindl A; Bartram CR; Schmutzler RK; Burwinkel B
    Breast Cancer Res Treat; 2010 Jun; 121(3):693-702. PubMed ID: 19921425
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The association between two polymorphisms in pre-miRNAs and breast cancer risk: a meta-analysis.
    Gao LB; Bai P; Pan XM; Jia J; Li LJ; Liang WB; Tang M; Zhang LS; Wei YG; Zhang L
    Breast Cancer Res Treat; 2011 Jan; 125(2):571-4. PubMed ID: 20640596
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polymorphisms involved in the miR-218-LAMB3 pathway and susceptibility of cervical cancer, a case-control study in Chinese women.
    Zhou X; Chen X; Hu L; Han S; Qiang F; Wu Y; Pan L; Shen H; Li Y; Hu Z
    Gynecol Oncol; 2010 May; 117(2):287-90. PubMed ID: 20163849
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of polymorphisms in circadian pathway genes in breast tumorigenesis.
    Dai H; Zhang L; Cao M; Song F; Zheng H; Zhu X; Wei Q; Zhang W; Chen K
    Breast Cancer Res Treat; 2011 Jun; 127(2):531-40. PubMed ID: 20978934
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic variation in an miRNA-1827 binding site in MYCL1 alters susceptibility to small-cell lung cancer.
    Xiong F; Wu C; Chang J; Yu D; Xu B; Yuan P; Zhai K; Xu J; Tan W; Lin D
    Cancer Res; 2011 Aug; 71(15):5175-81. PubMed ID: 21676885
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Three circadian clock genes Per2, Arntl, and Npas2 contribute to winter depression.
    Partonen T; Treutlein J; Alpman A; Frank J; Johansson C; Depner M; Aron L; Rietschel M; Wellek S; Soronen P; Paunio T; Koch A; Chen P; Lathrop M; Adolfsson R; Persson ML; Kasper S; Schalling M; Peltonen L; Schumann G
    Ann Med; 2007; 39(3):229-38. PubMed ID: 17457720
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A genetic variant located in miR-423 is associated with reduced breast cancer risk.
    Smith RA; Jedlinski DJ; Gabrovska PN; Weinstein SR; Haupt L; Griffiths LR
    Cancer Genomics Proteomics; 2012; 9(3):115-8. PubMed ID: 22593246
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Spectroscopic and DNA-binding characterization of the isolated heme-bound basic helix-loop-helix-PAS-A domain of neuronal PAS protein 2 (NPAS2), a transcription activator protein associated with circadian rhythms.
    Mukaiyama Y; Uchida T; Sato E; Sasaki A; Sato Y; Igarashi J; Kurokawa H; Sagami I; Kitagawa T; Shimizu T
    FEBS J; 2006 Jun; 273(11):2528-39. PubMed ID: 16704425
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The circadian gene NPAS2 is a novel prognostic biomarker for breast cancer.
    Yi C; Mu L; de la Longrais IA; Sochirca O; Arisio R; Yu H; Hoffman AE; Zhu Y; Katsaro D
    Breast Cancer Res Treat; 2010 Apr; 120(3):663-9. PubMed ID: 19649706
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ala394Thr polymorphism in the clock gene NPAS2: a circadian modifier for the risk of non-Hodgkin's lymphoma.
    Zhu Y; Leaderer D; Guss C; Brown HN; Zhang Y; Boyle P; Stevens RG; Hoffman A; Qin Q; Han X; Zheng T
    Int J Cancer; 2007 Jan; 120(2):432-5. PubMed ID: 17096334
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A population-based case-control study of the Arg399Gln polymorphism in DNA repair gene XRCC1 and risk of breast cancer.
    Shu XO; Cai Q; Gao YT; Wen W; Jin F; Zheng W
    Cancer Epidemiol Biomarkers Prev; 2003 Dec; 12(12):1462-7. PubMed ID: 14693738
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A study on the association of cytochrome-P450 1A1 polymorphism and breast cancer risk in north Indian women.
    Singh V; Rastogi N; Sinha A; Kumar A; Mathur N; Singh MP
    Breast Cancer Res Treat; 2007 Jan; 101(1):73-81. PubMed ID: 16807674
    [TBL] [Abstract][Full Text] [Related]  

  • 17. REV3L 3'UTR 460 T>C polymorphism in microRNA target sites contributes to lung cancer susceptibility.
    Zhang S; Chen H; Zhao X; Cao J; Tong J; Lu J; Wu W; Shen H; Wei Q; Lu D
    Oncogene; 2013 Jan; 32(2):242-50. PubMed ID: 22349819
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circadian genes and breast cancer susceptibility in rotating shift workers.
    Monsees GM; Kraft P; Hankinson SE; Hunter DJ; Schernhammer ES
    Int J Cancer; 2012 Dec; 131(11):2547-52. PubMed ID: 22473669
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Further studies based on better design are needed to explore the association of NPAS2 gene polymorphisms with breast cancer.
    Wang F; Zou YF
    Breast Cancer Res Treat; 2011 Jun; 127(2):565-8. PubMed ID: 21234674
    [No Abstract]   [Full Text] [Related]  

  • 20. A variant affecting a putative miRNA target site in estrogen receptor (ESR) 1 is associated with breast cancer risk in premenopausal women.
    Tchatchou S; Jung A; Hemminki K; Sutter C; Wappenschmidt B; Bugert P; Weber BH; Niederacher D; Arnold N; Varon-Mateeva R; Ditsch N; Meindl A; Schmutzler RK; Bartram CR; Burwinkel B
    Carcinogenesis; 2009 Jan; 30(1):59-64. PubMed ID: 19028706
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.